« Back
Home /
Obinutuzumab/afutuzumab

Obinutuzumab/afutuzumab

Manufacturer	TargetMol
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Amount	5mg
Item no.	TMO-T9924-5mg
CASRN	949142-50-1
eClass 6.1	32169090
eClass 9.0	32169090
Available
Short Description	Obinutuzumab GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma.
Shipping	cool pack
Storage	-20°
Target names or alias	Obinutuzumab/afutuzumab
Molecular Weight	150 kDa

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5mg

available

Delivery expected until 5/9/2024